Browse studies, page 1116
Page 1116 of 1,159, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Impact of multisite colonization and comparative microbiological outcomes of colistin-sulbactam vs. colistin-tigecycline in CRAB hospital-acquired pneumonia: a propensity score-matched analysis Frontiers in Cellular and Infection Microbiology, 2026
- Safety and Efficacy of Incentive Spirometer in Covid-19 Pneumonia; a Randomized Clinical Trial Archives of Academic Emergency Medicine, 2024
- Efficacy and Safety of IL-6 Inhibitors in Patients with COVID-19 Pneumonia: A Systematic Review and Meta-Analysis of Multicentre, Randomised Trials Social Science Research Network, 2021
- Effects of prophylactic nebulized antibiotics on the prevention of ICU-acquired pneumonia: a systematic review and meta-analysis PeerJ, 2024
- A55-50 A Biomarker-based AI Tool That Predicts Corticosteroid Treatment Benefit or Harm in Pneumonia American Journal of Respiratory and Critical Care Medicine, 2026
- Intravenous combined with aerosolised polymyxins versus intravenous polymyxins monotherapy for ventilator-associated pneumonia: a systematic review and meta-analysis International Journal of Antimicrobial Agents, 2024
- Clinical Efficacy of Doripenem in Treating Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis THE ULUTAS MEDICAL JOURNAL, 2022
- The prediction of lymphocyte count and neutrophil count on the efficacy of Xuebijing adjuvant treatment for severe community-acquired pneumonia: A post hoc analysis of a randomized controlled trial Phytomedicine, 2022
- Efficacy of comprehensive unit-based safety program to prevent ventilator associated-pneumonia for mechanically ventilated patients in China: A propensity-matched analysis Frontiers in Public Health, 2022
- Efficacy and Safety of Ceftaroline Fosamil in Hospitalized Patients with Community-Acquired Pneumonia in China: Subset Analysis of an International Phase 3 Randomized Controlled Trial Infection and Drug Resistance, 2022
- Study of the efficacy and safety of hexapeptide succinate in hospitalized patients with community-acquired pneumonia: a single-blind, multicenter, randomized, comparative, placebo-controlled study PULMONOLOGIYA, 2025
- Beta-lactam plus macrolide treatment versus beta-lactam monotherapy for community-acquired pneumonia: a propensity score analysis using data from a multicenter prospective cohort study BMC Infectious Diseases, 2025
- Efficacy and Safety of Intravenous-to-Oral Lascufloxacin Switch Therapy in Community-Onset Pneumonia: A Single-Arm, Open-Label Clinical Trial Cureus, 2025
- Efficacy of instilled saline in conjunction with chest physiotherapy on secretion clearance in adults diagnosed with a ventilator acquired pneumonia: a randomised crossover feasibility trial Physiotherapy, 2025
- Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies Open Forum Infectious Diseases, 2021
- Statistical analysis plan for the “empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia” clinical trial Trials, 2025
- Efficacy and safety of Omadacycline in community-acquired pneumonia among elderly patients: a real-world evidence study Frontiers in Cellular and Infection Microbiology, 2026
- Imipenem/cilastatin/relebactam dosing regimen justification using exposure–efficacy analyses in participants with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia in the RESTORE-IMI 2 phase 3 study Antimicrobial Agents and Chemotherapy, 2026
- Efficacy, Safety, and Economic Evaluation of Originator Versus Generic Moxifloxacin Hydrochloride Injection in the Treatment of Community-Acquired Pneumonia Under China's National Centralized Drug Procurement Policy: A Retrospective Study Clinical Therapeutics, 2026
- Effect of a texture-modified and controlled bolus volume diet on all-cause mortality in older persons with oropharyngeal dysphagia: Secondary analysis of a randomized controlled trial Nutrition in clinical practice, 2023
- Efficacy and Nephrotoxicity of Extended versus Intermittent Infusion of Beta-Lactams for the Treatment of Ventilator Associated Pneumonia The Quarterly journal of medicine, 2024
- Comparative prospective cohort study of efficacy and safety according to dosage and administration of ceftriaxone for community-acquired pneumonia Journal of Infection and Chemotherapy, 2024
- Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol medRxiv, 2021
- Safety and efficacy of antimicrobial optimization based on negative results from BioFire FilmArray Pneumonia panel and respiratory culture Antimicrobial Stewardship and Healthcare Epidemiology, 2025
- Efficacy and safety of echinocandins combined with Trimethoprim-Sulfamethoxazole as first-line treatment for Pneumocystis pneumonia in HIV-infected and non-HIV-infected patients BMC Infectious Diseases, 2025
- Multicentre open-label randomised controlled trial comparing the efficacy and safety of colistin-based combination therapy with the best available therapy for treating hospital-acquired pneumonia or bloodstream infections caused by carbapenem-resistant Enterobacteriaceae (COUNT-CRE): a study protoco BMJ Open, 2025
- Efficacy of tocilizumab for hospitalized patients with COVID-19 pneumonia and high IL-6 levels: A randomized controlled trial Infection, 2025
- Clinical Efficacy and Safety of Omadacycline Versus Tigecycline in Treating Severe Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacilli: A Retrospective Cohort Study Infection and Drug Resistance, 2025
- Prediction of Antibiotic Efficacy in Cerebral Hemorrhage-Associated Pneumonia Using Inflammatory Hematological Indices: A Retrospective Study Journal of Inflammation Research, 2025
- Efficacy of Lefamulin for Community-Acquired Bacterial Pneumonia (CABP) Patients: Pooled Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 1, LEAP 2 and LEAP China Trials Infection and Drug Resistance, 2025
- Efficacy analysis of ultrashort wave therapy as adjunctive treatment for pediatric patients with macrolide-resistant Mycoplasma pneumoniae pneumonia Frontiers in Cellular and Infection Microbiology, 2025
- Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials European Respiratory Journal, 2019
- Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial BMJ Open Respiratory Research, 2020
- Supportive care in myeloma-when treating the clone alone is not enough Hematology. American Society of Hematology. Education Program, 2024
- Controversies in the management of ESBL-producing Enterabacterales. Clinical Implications Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2022
- The Effectiveness of Combination Therapy for Treating Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Literature Review and a Meta-Analysis Microorganisms, 2022
- Meropenem/Vaborbactam: β-Lactam/β-Lactamase Inhibitor Combination, the Future in Eradicating Multidrug Resistance Antibiotics (Basel, Switzerland), 2023
- Secukinumab for the treatment of generalized pustular psoriasis: A case report Medicine, 2023
- New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties Transplant international : official journal of the European Society for Organ Transplantation, 2024
- Macrolide Antibiotic Mediated Cardiac Arrhythmias: Emerging Concepts and Clinical Implications Biomedicines, 2025
- The safety of ceftolozane-tazobactam for the treatment of acute bacterial infections: a systemic review and meta-analysis Therapeutic advances in drug safety, 2021
- Clinical Evaluation of Omadacycline for Pulmonary Mycobacterium abscessus Complex Infections: A Subgroup Analysis With a Focus on Macrolide Resistance CHEST pulmonary, 2026
- Antimicrobial Usage Among Acutely Ill Hospitalized Children Aged 2‒23 Months in Sub-Saharan Africa and South Asia Open forum infectious diseases, 2025
- Combined use of respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in sickle-cell adult patients with acute chest syndrome (The ANTIBIO-STA study): a randomised, controlled, open-label trial The Lancet regional health. Europe, 2025
- Antibiotic prescribing for adults with group A streptococcal bacteremia in a large healthcare system Antimicrobial stewardship & healthcare epidemiology : ASHE, 2023
- Neutropenia and Infection Prophylaxis in Childhood Cancer Current oncology reports, 2022
- Korean Guidelines for the Management and Antibiotic Therapy in Adult Patients with Hospital-Acquired Pneumonia Tuberculosis and respiratory diseases, 2025
- A Review of Omadacycline for Potential Utility in the Military Health System for the Treatment of Wound Infections Military medicine, 2024
- Antimicrobial Treatment of Pseudomonas aeruginosa Severe Sepsis Antibiotics (Basel, Switzerland), 2022
- Ureaplasma urealyticum infection following organ transplantation: a case report and narrative review Renal failure, 2024
- Bacterial and Antibiotic Sensitivity Pattern in Secondary Peritonitis Journal of the West African College of Surgeons, 2022
- Current Evidence on the Usefulness of Potential Therapies in the Prevention of COPD Exacerbations: Beyond the Use of Bronchodilator Therapy and Inhaled Corticosteroids Open respiratory archives, 2025
- Ceftolozane-tazobactam: When, how and why using it? Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2021
- Antimicrobial resistance among children in Southeast Asia: a systematic review BMJ public health, 2025
- Utilization of Inhaled Antibiotics in Pediatric Non-Cystic Fibrosis Bronchiectasis: A Comprehensive Review Antibiotics (Basel, Switzerland), 2025
- Successful salvage of a severe COVID-19 patient previously with lung cancer and radiation pneumonitis by mesenchymal stem cells: a case report and literature review Frontiers in immunology, 2024
- A bacteriophage cocktail targeting Yersinia pestis provides strong post-exposure protection in a rat pneumonic plague model Microbiology spectrum, 2024
- Assessment of Predictive Factors That Shorten Duration of Treatment in Patients With Multiple Myeloma Using AI: Real-World Longitudinal Study Using Data From Medical Data Vision Claims Database JMIR cancer, 2026
- Efficacy and Safety of Plazomicin in the Treatment of Enterobacterales Infections: A Meta-analysis of Randomized Controlled Trials Open forum infectious diseases, 2022
- Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia British journal of haematology, 2026
- Antibacterial potential, DNA binding and molecular docking investigations of newly green synthesized zinc oxide/chitosan/vancomycin nanocomposite using Bacillus licheniformis ATCC 4527 against some drug-resistant bacteria Microbial cell factories, 2026
- Suicidal thoughts and behaviors associated with fluoroquinolone antibiotics: a real-world pharmacovigilance analysis Frontiers in pharmacology, 2025
- Bloodstream Infection and Gram-Negative Resistance: The Role for Newer Antibiotics Antibiotics (Basel, Switzerland), 2023
- Nosocomial lower respiratory tract infections in patients with immunosuppression: a cohort study Annals of intensive care, 2025
- Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations Antimicrobial agents and chemotherapy, 2025
- Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections Infection & chemotherapy, 2024
- Omadacycline for Diverse Infections in China: A Real-World Analysis of Efficacy and Safety Infectious diseases and therapy, 2024
- Granulocyte Transfusions in Neutropenic Infections: Insights From a Single-Center Study Cureus, 2024
- Balancing Efficacy and Safety in Multiple Myeloma Patients Receiving B cell Maturation Antigen-Directed CAR T-Cell Therapy BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2026
- Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice The Journal of antimicrobial chemotherapy, 2025
- Intravenous Fosfomycin for Gram-Negative and Gram-Positive Bacterial Infections: A Systematic Review of the Clinical Evidence Antibiotics (Basel, Switzerland), 2025
- Guideline-Concordant Antibiotic Use in Children With Community-Acquired Pneumonia Hospital pediatrics, 2025
- Clinical and evidence-based considerations for choosing a pneumococcal conjugate vaccine in India: A narrative review Human vaccines & immunotherapeutics, 2025
- Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group Clinical hematology international, 2025
- N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR) Frontiers in medicine, 2026
- Eravacycline Treatment for Carbapenem-Resistant Acinetobacter baumannii in Lung Transplant Recipients: A Real-World Retrospective Study Infection and drug resistance, 2025
- Compassionate Use of Encapsulated MKB-01 Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection: A Single-Center Experience Microorganisms, 2025
- Optimized green zinc oxide/chitosan/amoxicillin nanocomposite against Pseudomonas aeruginosa Applied microbiology and biotechnology, 2026
- Management of extensively drug-resistant Acinetobacter baumannii bacteremia with cefiderocol and sulbactam-durlobactam: a case report ASM case reports, 2025
- Innovative Antibiotics: The Experience of Cefiderocol in Carbapenem-Resistant Gram-Negative Infections Infection and drug resistance, 2026
- Beyond traditional tetracyclines: a real-world evaluation of effectiveness and safety of omadacycline therapy for complex bacterial infections BMC infectious diseases, 2026
- Mycobacterium intracellulare Infection in a Japanese Patient with Signal Transducer and Activator of Transcription-3 Gain-of-function Syndrome Internal medicine (Tokyo, Japan), 2026
- The Role of Combination Antibiotic Therapy in Combatting Drug-Resistant Acinetobacter baumannii Infections: A Systematic Review of Randomised Control Trials Antibiotics (Basel, Switzerland), 2026
- Perspectives on the use of ceftolozane/tazobactam: a review of clinical trial data and real-world evidence Future microbiology, 2024
- Nanomaterial strategies for antibiotic-resistant infections: Mechanistic frameworks, rational design, and clinical translation Materials today. Bio, 2026
- Real-world use of novel β-lactams in immunologically vulnerable patients: insights from an Italian retrospective cohort JAC-antimicrobial resistance, 2026
- Infectious, inflammatory, and clinical outcomes among patients prescribed trifluoperazine or amoxapine: a retrospective cohort study using real-world data Frontiers in medicine, 2026
- Streamlining antibiotic use in community acquired pneumonia: A quality improvement initiative Journal of hospital medicine, 2026
- Treatment of Carbapenem-Resistant Gram-Negative Bacterial Infections with Polymyxins: A Review Infection and drug resistance, 2025
- Comparative efficacy of ceftolozane-tazobactam versus ceftazidime-avibactam for Pseudomonas aeruginosa infections: a GRADE-assessed systematic review and meta-analysis Annals of medicine and surgery (2012), 2026
- Evaluating the effectiveness and safety of Xiyanping injection for severe pneumonia: a target trial emulation protocol using real-world data Frontiers in Pharmacology, 2026
- The Therapeutic Efficacy of Abatacept for Rheumatoid Arthritis-Associated Interstitial Lung Disease: Insights from a 12-Month Trial Using Semi-Quantitative Chest High-Resolution Computed Tomography Imaging Journal of Clinical Medicine, 2024
- Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial Contemporary Clinical Trials, 2023
- A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study) Clinical Infectious Diseases, 2020
- Efficacy and safety of SMET12 in combination with toripalimab and chemotherapy in advanced non-small-cell lung cancer patients tested positive for EGFR protein who are treatment-naïve or harbor acquired resistance to standard therapy: a phase 2, multi-cohort clinical trial Frontiers in Immunology, 2026
- Results of a Double-Blind Prospective Comparative Randomized Phase 3 Clinical Trial of the Efficacy and Safety of BCD-264 and Darzalex as Monotherapy for Relapsed/Refractory Multiple Myeloma (BCD-264-2/DARVIVA) Clinical oncohematology, 2026
- Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia: The LEAP 2 Randomized Clinical Trial Journal of the American Medical Association (JAMA), 2019
- Preliminary efficacy and safety of camrelizumab combined with cetuximab and chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A phase II clinical trial Journal of Clinical Oncology, 2024
- Effectiveness of Hyperbaric Oxygen Therapy in SARS-CoV-2 Pneumonia: The Primary Results of a Randomised Clinical Trial Journal of Clinical Medicine, 2022
- Clinical study on modified Shenzhe Zhenqi Decoction combined with ambroxol hydrochloride in the treatment of severe pneumonia Frontiers in Physiology, 2025
